XUE [Xueda Education] SC 13D/A: (Original Filing)

[CUSIP No. 98418W109 1 NAME OF REPORTING PERSON Xiamen Insight Investment Co., Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) ¨ ¨ (a) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) OO 5 ¨ 6 CITIZENSHIP OR PLACE OF ORGANIZATION People’s Republic of China NUMBER OF]

By | 2016-06-04T02:53:28+00:00 June 3rd, 2016|Categories: Chinese Stocks, SEC Original, XUE|Tags: , , , , , |0 Comments

XUE [Xueda Education] SC 13E3/A: (Original Filing)

[SCHEDULE 13E-3 (Amendment No. 5) Xueda Education Group (Name of the Issuer) Xueda Education Group (Names of Persons Filing Statement) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 98418W109 (CUSIP Number) Ross Warner Wang Yin Hao Ji Rubin Li Xin Jin Jinbo Yao (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)]

By | 2016-06-04T02:57:05+00:00 June 3rd, 2016|Categories: Chinese Stocks, SEC Original, XUE|Tags: , , , , , |0 Comments

XUE [Xueda Education] 6-K: (Original Filing)

[Xueda Education Group Announces Completion of Going Private Transaction Registered shareholders entitled to the Merger consideration as described above will receive a letter of transmittal and instructions on how to surrender their share certificates in exchange for the Merger consideration from the paying agent appointed by Parent and should wait to receive the letter of transmittal before surrendering their share] [TABLE OF CONTENTS 2 XUEDA EDUCATION GROUP]

By | 2016-06-04T02:58:45+00:00 June 3rd, 2016|Categories: Chinese Stocks, SEC Original, XUE|Tags: , , , , , |0 Comments

IDI [IDI] S-8: (Original Filing)

[] [Las Olas Centre II, Suite 1600 350 East Las Olas Boulevard Fort Lauderdale, FL 33301-2999 Tel: 954.463.2700 Fax: 954.463.2224 June 3, 2016 IDI, Inc. 2650 North Military Trail Suite 300 Boca Raton, FL 33431 Re: Registration Statement on Form S-8 Ladies and Gentlemen: Company Commission Registration Statement Act Shares Awards Plan RSUs Brauser Plan Frost Plan We have acted as] [IDI, INC. 2015 STOCK INCENTIVE PLAN 1. ESTABLISHMENT, EFFECTIVE DATE AND TERM 2. PURPOSE The purpose of the Plan is to enable IDI to attract, retain, reward and motivate Eligible Individuals by providing them with an opportunity to acquire or increase a proprietary interest in IDI and to incentivize them to expend maximum effort for the growth and success of] [AMENDMENT TO THE IDI, INC. 2015 STOCK INCENTIVE PLAN WHEREAS WHEREAS WHEREAS NOW, THEREFORE The last sentence of Section 5(a) of the Plan shall be amended and restated to read as follows: Section 5(b) of the Plan shall be amended and restated to read as follows: Certain Limitations on Specific Types of Awards . “ (v) The maximum value at] [RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT th Award and Definitions 1. Shares (a) Definitions . (b) Cause (i) “ Change in Control (ii) “ Code (iii) “ Common Stock (iv) “ Committee (v) “ Disability (vi) “ EBITDA (vii) “ Employment Agreement (viii) “ Good Reason (ix) “ Section 409A (x) “ Restricted Stock Units 2. Vesting (a) Date Total] [RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT th Award and Definitions 1. Shares (a) Definitions . (b) Change in Control (i) “ Code (ii) “ Common Stock (iii) “ “ Committee ” (iv) Section 409A (v) “ Restricted Stock Units 2. Vesting (a) Transferability (b) Distribution (c) Withholding 3. Status as a Shareholder 4. Binding Effect 5. Governing Law 6. Miscellaneous] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our reports dated March 15, 2016 with respect to the consolidated financial statements and internal control over financial reporting of IDI, Inc. included in the Annual Report on Form 10-K for the year ended December 31, 2015, which are incorporated by reference in this Registration Statement. We consent to the] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Form S-8 As independent registered public accountants, we consent to the incorporation by reference in this Registration Statement on New York, New York June 2, 2016 EX-23.3 8 d199884dex233.htm EX-23.3] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM New York, New York June 3, 2016 EX-23.4 9 d199884dex234.htm EX-23.4] [Consent of Independent Auditors New York, New York June 3, 2016 EX-23.5 10 d199884dex235.htm EX-23.5]

By | 2016-06-04T03:01:14+00:00 June 3rd, 2016|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

OIIM [O2MICRO INTERNATIONAL] SC 13G/A: (Original Filing)

[CUSIP NO. 67107W 10 0 Page 2 of 6 1. Name of reporting persons: I.R.S. Identification Nos. of above persons (entities only): DNB Asset Management AS 2. Check the appropriate box if a member of a group: ¨ ¨ (a) 3. SEC use only: 4. Citizenship or place of organization: Kingdom of Norway Number of shares beneficially owned by each]

SEED [Origin Agritech] SC 13D/A: (Original Filing)

[Joint Filing Agreement [ Liang Yuan Liang Yuan Bonasmart Limited Liang Yuan Director EX-99.1 2 d193821dex991.htm EX-99.1] [13D CUSIP No. G67828106 Page 2 of 7 Pages 1 Names of reporting persons Liang Yuan 2 Check the appropriate box if a member of a group (see instructions) ¨ ¨ (a) 3 SEC use only 4 Source of funds (see instructions) OO 5 ¨ 6 Citizenship or place of organization The Hong Kong Special Administrative Region of the People’s]

By | 2016-06-03T13:09:36+00:00 June 2nd, 2016|Categories: Chinese Stocks, SEC Original, SEED|Tags: , , , , , |0 Comments

WUBA [58.com] 6-K: (Original Filing)

[58.com Reports First Quarter 2016 Unaudited Financial Results BEIJING, June 2, 2016 --58.com Inc. (NYSE: WUBA) (“58.com” or the “Company”), China’s largest online market place serving local merchants and consumers, today reported its unaudited financial results for the first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights · Total revenues were US$231.3 million, a 165.6% increase from the] []

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited First Quarter 2016 Financial Results BEIJING, May 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights (compared to the first quarter of 2015) • Quarterly sales from continuing operations were $11.0 million, an increase] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v441538_6k.htm FORM 6-K]

By | 2016-06-03T13:21:02+00:00 June 2nd, 2016|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Skip to toolbar